160 related articles for article (PubMed ID: 6124227)
21. Pressure compliance test of the optic nerve head: influence of different antiglaucoma drugs.
Pillunat LE; Stodtmeister R
Surv Ophthalmol; 1989 Apr; 33 Suppl():465-6; discussion 471-2. PubMed ID: 2568699
[No Abstract] [Full Text] [Related]
22. The acute and chronic effects of betaxolol on blood pressure, renin-aldosterone, and renal function in essential hypertension.
Reams GP; Bauer JH; Lau A
J Clin Pharmacol; 1987 Feb; 27(2):118-21. PubMed ID: 2890665
[TBL] [Abstract][Full Text] [Related]
23. A double-masked three-month comparison between 0.25% betaxolol suspension and 0.5% betaxolol ophthalmic solution.
Weinreb RN; Caldwell DR; Goode SM; Horwitz BL; Laibovitz R; Shrader CE; Stewart RH; Williams AT
Am J Ophthalmol; 1990 Aug; 110(2):189-92. PubMed ID: 2198812
[TBL] [Abstract][Full Text] [Related]
24. Effects of glaucoma medications on the cardiorespiratory and intraocular pressure status of newly diagnosed glaucoma patients.
Waldock A; Snape J; Graham CM
Br J Ophthalmol; 2000 Jul; 84(7):710-3. PubMed ID: 10873979
[TBL] [Abstract][Full Text] [Related]
25. A comparison of the efficacy of betaxolol and timolol in ocular hypertension with or without adrenaline.
Clark JB; Brooks AM; Harper CA; Mantzioros N; Gillies WE
Aust N Z J Ophthalmol; 1989 May; 17(2):173-7. PubMed ID: 2569321
[TBL] [Abstract][Full Text] [Related]
26. The lack of efficacy of topical beta-blockers, timolol and betaxolol on intraocular pressure in Nigerian healthy volunteers.
Olateju SO; Ajayi AA
Eye (Lond); 1999 Dec; 13 ( Pt 6)():758-63. PubMed ID: 10707140
[TBL] [Abstract][Full Text] [Related]
27. Betaxolol vs timolol. A six-month double-blind comparison.
Stewart RH; Kimbrough RL; Ward RL
Arch Ophthalmol; 1986 Jan; 104(1):46-8. PubMed ID: 3510612
[TBL] [Abstract][Full Text] [Related]
28. Ocular hypotensive efficacy and safety of a combined formulation of betaxolol and pilocarpine.
Robin AL
Trans Am Ophthalmol Soc; 1996; 94():89-101; discussion 101-3. PubMed ID: 8981691
[TBL] [Abstract][Full Text] [Related]
29. Pressure-reducing efficacy and tolerability of betaxolol in ionic solution.
Troiano P; Cavallotti B; Iraci M; Galli L; Miglior M
Acta Ophthalmol Scand Suppl; 1997; (224):18-20. PubMed ID: 9589712
[No Abstract] [Full Text] [Related]
30. Effect of adding betaxolol to dipivefrin therapy.
Weinreb RN; Ritch R; Kushner FH
Am J Ophthalmol; 1986 Feb; 101(2):196-8. PubMed ID: 3946535
[TBL] [Abstract][Full Text] [Related]
31. Betaxolol.
Goldberg I
Aust N Z J Ophthalmol; 1989 Feb; 17(1):9-13. PubMed ID: 2569884
[TBL] [Abstract][Full Text] [Related]
32. Betaxolol eye drops. A clinical trial of safety and efficacy.
Goldberg I; Goldberg H
Aust N Z J Ophthalmol; 1995 Feb; 23(1):17-24. PubMed ID: 7619450
[TBL] [Abstract][Full Text] [Related]
33. Cardiovascular effects of befunolol, betaxolol and timolol eye drops.
Dorigo MT; Cerin O; Fracasso G; Altafini R
Int J Clin Pharmacol Res; 1990; 10(3):163-6. PubMed ID: 1977708
[TBL] [Abstract][Full Text] [Related]
34. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial.
Heijl A; Leske MC; Bengtsson B; Hyman L; Bengtsson B; Hussein M;
Arch Ophthalmol; 2002 Oct; 120(10):1268-79. PubMed ID: 12365904
[TBL] [Abstract][Full Text] [Related]
35. Effects of topically applied falintolol: a new beta-adrenergic antagonist for treatment of glaucoma.
Himber J; Sallee VL; Andermann G; Bouzoubaa M; Leclerc G; De Santis L
J Ocul Pharmacol; 1987; 3(2):111-20. PubMed ID: 2903204
[TBL] [Abstract][Full Text] [Related]
36. [Additional experience with the beta blocker befunolol (Glaukonex) in open-angle glaucoma over a period of 1 year].
Merté HJ; Stryz JR
Klin Monbl Augenheilkd; 1984 Apr; 184(4):316-7. PubMed ID: 6144813
[TBL] [Abstract][Full Text] [Related]
37. Effects of latanoprost and betaxolol on cardiovascular and respiratory status of newly diagnosed glaucoma patients.
Erkin EF; Celik P; Kayikçioğlu O; Deveci HM; Sakar A
Ophthalmologica; 2006; 220(5):332-7. PubMed ID: 16954712
[TBL] [Abstract][Full Text] [Related]
38. Betaxolol and timolol.
Harrison R
Arch Ophthalmol; 1984 Oct; 102(10):1424, 1426. PubMed ID: 6148923
[No Abstract] [Full Text] [Related]
39. Changing antiglaucoma therapy from timolol to betaxolol: effect on ocular blood flow.
Rainer G; Dorner GT; Garhöfer G; Vass C; Pfleger T; Schmetterer L
Ophthalmologica; 2003; 217(4):288-93. PubMed ID: 12792136
[TBL] [Abstract][Full Text] [Related]
40. A double-masked, randomized, 1-year study comparing the corneal effects of dorzolamide, timolol, and betaxolol. Dorzolamide Corneal Effects Study Group.
Lass JH; Khosrof SA; Laurence JK; Horwitz B; Ghosh K; Adamsons I
Arch Ophthalmol; 1998 Aug; 116(8):1003-10. PubMed ID: 9715679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
